Research indicates savings could be made in diabetic retinopathy screening costs

South West PeninsulaMetabolic and Endocrine
Published Date: 1 Jun 2012

Research indicates savings could be made in diabetic retinopathy screening costs

Who is this relevant to?

Those with responsibility for the delivery of or an interest in diabetic retinopathy

Background

Diabetic retinopathy is a common complication of diabetes. It occurs when high blood sugar levels damage the cells in the retina and, if not treated, can lead to blindness. In all but some cases diabetic retinopathy has a slow rate of progression and can take years to develop. We developed a model that simulates the progression of retinopathy in type 2 diabetes in order to predict the rates of retinopathy-related sight loss which screening may prevent. The model used data from patients with type 2 diabetes in Devon. We generated comparative 15-year forecasts looking at the difference between current annual screening and a policy whereby people who have not developed retinopathy are screened every two years.